The MarketWatch News Department was not involved in the creation of this content.-- This marks the first live procedure at AAHS, as well as a first for Keenova. -- Treatment takes ...

Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or CCH) will be shared at the American ...

September 17, 2009 — The US Food and Drug Administration (FDA)'s Arthritis Advisory Committee voted unanimously (12 to 0) yesterday to recommend approval of collagenase clostridium histolyticum ...

MALVERN, Pa., Nov. 20, 2024 /CNW/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment ...

DUBLIN, June 5, 2023 /PRNewswire/ -- Endo International plc (ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX ® (collagenase clostridium histolyticum, or CCH, injection ...

Campaign builds on the momentum of Endo's disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal ...

Endo is ramping up the next phase of its Dupuytren's contracture marketing drive. Not long after running its first branded ad for Xiaflex in the indication, the drugmaker has dubbed September the ...

In a large, head-to-head trial pitting collagenase injections against limited fasciotomy as treatments for Dupuytren's contracture, the knife won. In the open-label trial, self-reported hand health ...

Analysis to Be Presented at the American Association for Hand Surgery Meeting DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a ...

MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his ...